Results 21 to 30 of about 7,249,751 (246)
Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer
Minu K Srivastava,1,2 Li Zhu,1,2 Marni Harris-White,2 Min Huang,1–3 Maie St John,1,3 Jay M Lee,1,3 Ravi Salgia,4 Robert B Cameron,1,3,5 Robert Strieter,6 Steven Dubinett,1–3 Sherven Sharma1–31Department of Medicine, UCLA Lung Cancer ...
Srivastava MK +10 more
doaj +1 more source
Therapeutic targeting of myeloid-derived suppressor cells
Myeloid-derived suppressor cells (MDSCs) represent a subset of myeloid cells that expand under pathological conditions, such as cancer development, acute and chronic infections, trauma, bone marrow transplantations, and some autoimmune diseases. MDSCs mediate a negative regulation of the immune response by affecting different T lymphocyte subsets ...
Ugel, Stefano +7 more
openaire +4 more sources
EBV and myeloid-derived suppressor cells [PDF]
In this issue of Blood, Collins et al have developed a novel multicolor flow cytometry technology to reveal a crucial role of myeloid-derived suppressor cells in Epstein-Barr virus (EBV)-associated lymphoproliferative diseases. In particular this study focuses on EBV-positive natural killer (NK) cell and T-cell proliferation.(1)
Debottam Sinha, Rajiv Khanna
openaire +4 more sources
Myeloid derived suppressor cells [PDF]
The goal of achieving measurable response with cancer immunotherapy requires counteracting the immunosuppressive characteristics of tumors. One of the mechanisms that tumors utilize to escape immunosurveillance is the activation of myeloid derived suppressor cells (MDSCs).
Waldron, Todd J. +4 more
openaire +2 more sources
Myeloid-Derived Suppressor Cells [PDF]
Abstract Myeloid cells developed evolutionarily as a major mechanism to protect the host. They evolved as a critical barrier against infections and are important contributors to tissue remodeling. However, in cancer, myeloid cells are largely converted to serve a new master—tumor cells.
openaire +4 more sources
Myeloid-Derived Suppressor Cells in Sepsis [PDF]
Sepsis is a systemic, deleterious host response to widespread infection. Patients with sepsis will have documented or suspected infection which can progress to a state of septic shock or acute organ dysfunction. Since sepsis is responsible for nearly 3 million cases per year in China and severe sepsis is a common, expensive fatal condition in America ...
Dengming Lai, Chaojin Qin, Qiang Shu
openaire +2 more sources
Myeloid derived suppressor cells and autoimmunity [PDF]
Myeloid-derived suppressor cells are a heterogeneous group of immature myeloid cells with immunoregulatory function. When activated and expanded, these cells can suppress T cell functions via cell-to cell interactions as well as soluble mediators. Recent studies investigated the involvement of MDSC in autoimmune diseases.
Peter, Boros +2 more
openaire +2 more sources
History of myeloid-derived suppressor cells [PDF]
Tumour-induced granulocytic hyperplasia is associated with tumour vasculogenesis and escape from immunity via T cell suppression. Initially, these myeloid cells were identified as granulocytes or monocytes; however, recent studies have revealed that this hyperplasia is associated with populations of multipotent progenitor cells that have been ...
James E, Talmadge, Dmitry I, Gabrilovich
openaire +2 more sources
Neutrophils as myeloid‐derived suppressor cells [PDF]
AbstractNeutrophils form the first line of defence against invading pathogens, such as bacteria and fungi, as part of the innate immune response. Recently, neutrophils have also been discovered as repressors of adaptive immune responses. Under certain conditions, such as cancer and severe injury, an expansion of immature and mature neutrophils has been
Cathelijn E. M. Aarts, Taco W. Kuijpers
openaire +2 more sources
Myeloid-derived suppressor cells in cancer
Numerous recent studies have shown that myeloid-derived suppressor cells (MDSCs), a strongly heterogeneous population of immunosuppressive cells, are dysregulated in the presence of many cancers. MDSCs present different phenotypes and play prominent roles in the tumor microenvironment. To date, gene therapies targeting MDSCs are the most innovative and
Gao, Jun +4 more
openaire +2 more sources

